Medical Aesthetics

Exosome Treatment in Istanbul

Exosome-based products have become increasingly discussed in aesthetic medicine for skin quality, procedural recovery and hair-related applications.

  • LocationNişantaşı clinic
  • Session planTailored to you
  • Daily lifeVaries by person
  • Pre-assessmentOnline, with photos

However, “exosome treatment” is a broad term rather than one standardized procedure.

Different products may differ substantially in:

  • Cellular source
  • Manufacturing process
  • Purification
  • Characterization
  • Concentration
  • Formulation
  • Intended route of administration
  • Regulatory status

This makes product selection particularly important.

The first distinction is also fundamental:

Exosomes are not stem cells.

They are extracellular vesicles involved in communication between cells. A product derived from cells should not automatically be described as a stem-cell treatment.

What Are Exosomes?

Exosomes are very small extracellular vesicles released by cells.

Cells use extracellular vesicles as part of complex intercellular communication.

These vesicles can carry biological cargo such as:

  • Proteins
  • Lipids
  • Nucleic-acid-related molecules
  • Signaling molecules

Their exact composition depends on the cell of origin and biological environment.

Are Exosomes Stem Cells?

No.

A stem cell is a living cell with specific biological characteristics.

An exosome is a cell-free extracellular vesicle.

Therefore:

stem cell ≠ exosome

Even when an exosome preparation originates from cultured stem or stromal cells, the final extracellular vesicles are not themselves stem cells.

The phrase “stem-cell exosome treatment” should therefore be interpreted carefully.

What Is Extracellular Vesicle Therapy?

Extracellular vesicle is the broader scientific category.

Exosomes represent one subset within the extracellular-vesicle spectrum.

In commercial aesthetic medicine, the term “exosome” is sometimes used broadly.

However, proving that a product contains a specifically characterized exosome population requires appropriate laboratory characterization.

For patients, this means that the word “exosome” on a product label is not by itself sufficient information about product quality.

How Are Exosome Products Produced?

Depending on the product, extracellular-vesicle preparations may be obtained from conditioned cell-culture systems and then undergo processing and purification.

The source and manufacturing process matter because they influence the final biological composition.

Important questions include:

  • What is the biological source?
  • How is the material produced?
  • How is it purified?
  • How is it characterized?
  • Is sterility appropriately controlled?
  • How is it stored?
  • What route of administration is intended?
  • What clinical evidence exists for that specific product?

These questions are more meaningful than simply asking how many “billions of exosomes” a vial claims to contain.

Are All Exosome Products the Same?

No.

This is one of the most important points.

Products marketed as exosome treatments can differ substantially.

Differences may involve:

  • Source material
  • Isolation method
  • Purity
  • Particle characteristics
  • Protein contamination
  • Other extracellular-vesicle populations
  • Added ingredients
  • Storage requirements
  • Manufacturing quality
  • Clinical evidence

Therefore, evidence from one preparation cannot automatically be transferred to every other product marketed as an exosome.

How Do Exosomes Work?

Extracellular vesicles participate in biological signaling between cells.

Their cargo may influence cellular behavior and tissue responses.

This has generated significant research interest in fields involving:

  • Tissue repair
  • Inflammation
  • Wound healing
  • Angiogenesis
  • Skin biology
  • Hair-follicle biology

However, biological plausibility is not the same as proven clinical effectiveness for every commercial aesthetic product.

Exosomes in Aesthetic Medicine

Depending on the specific product and regulatory framework, exosome-based or extracellular-vesicle-based products are discussed for:

  • Skin-quality treatments
  • Post-procedural applications
  • Microneedling protocols
  • Laser-related protocols
  • Hair and scalp treatments

The evidence, formulation and intended use can vary considerably between products.

For this reason, “exosome facial” should not be treated as one universally standardized procedure.

Exosomes for Skin Quality

Exosome-related products are being investigated and marketed for skin-quality concerns including:

  • Fine texture
  • Signs of photoaging
  • Superficial fine lines
  • Overall skin appearance
  • Recovery after selected procedures

However, these treatments should not be expected to replace structural treatments when the actual problem is:

  • Facial volume loss
  • Skeletal deficiency
  • Jowling
  • Significant skin laxity
  • Deep wrinkles caused by tissue descent

Skin biology and facial anatomy are different treatment levels.

Exosomes and Microneedling

One commonly discussed approach is the use of extracellular-vesicle-containing products in association with microneedling.

Microneedling creates controlled microchannels and mechanical injury.

The exosome-related product represents a biologically active formulation used around the procedure.

These are different components of the treatment.

An important issue is that placing a product on disrupted skin is not equivalent to applying an ordinary cosmetic serum.

Product:

  • Sterility
  • Formulation
  • Intended route
  • Manufacturing quality

become particularly important when the skin barrier has been disrupted.

Exosomes and Fractional Laser

Exosome products are also discussed in combination with fractional laser procedures.

The laser creates the controlled tissue injury responsible for resurfacing.

An exosome preparation does not replace this laser effect.

When combination treatment is considered, the objective may involve post-procedural biological response or recovery rather than simply “making the laser stronger.”

Exosomes for Acne Scars

Exosome-based products may be investigated as adjuncts to procedures used for acne scars.

However, an extracellular-vesicle product cannot mechanically correct the architecture of every scar.

For example:

  • Tethered rolling scars may require subcision
  • Ice-pick scars may require focal treatment
  • Boxcar scars may require resurfacing or other approaches

Exosomes should therefore not be presented as a universal scar-erasing injection.

Exosome Hair Treatment

Hair and scalp treatment is another area in which exosome-based products have attracted substantial interest.

The proposed rationale involves biological signaling around the hair follicle and its surrounding tissue environment.

However, the same fundamental rule that applies to PRP also matters here:

A treatment aimed at supporting follicular biology should not be expected to create a new follicle where the follicle has been permanently lost.

Hair loss should first be diagnosed.

Exosomes for Androgenetic Alopecia

Extracellular-vesicle-based approaches are being investigated for androgenetic alopecia and follicular miniaturization.

However, the clinical evidence and standardization are less mature than the marketing language surrounding many commercial products may suggest.

Patients should therefore not be promised:

  • Guaranteed regrowth
  • Permanent reversal of androgenetic alopecia
  • Creation of new follicles
  • An alternative equivalent to hair transplantation in completely bald areas

Exosome Treatment vs Hair Transplantation

The concepts are fundamentally different.

Exosome-Based Treatment

Attempts to influence the biological environment of existing follicles.

Hair Transplantation

Physically relocates viable follicles from a donor area to an area requiring follicular replacement.

No cell-free topical or injectable biological product should be described as creating the same anatomical result as transplantation.

Exosomes vs PRP

These are different treatment concepts.

PRP

Is prepared from the patient's own blood and contains platelets, plasma and multiple biological mediators.

Exosome-Based Products

Contain extracellular-vesicle-related material obtained and manufactured according to the specific product.

PRP is autologous.

Commercial exosome products generally involve a manufactured preparation.

One should not automatically be described as a stronger version of the other.

Exosomes vs Polynucleotides / Salmon DNA

They are not the same.

Exosomes → extracellular vesicles

PN/PDRN → nucleotide-based materials

Their biological composition and proposed mechanisms differ substantially.

Exosomes vs NCTF

NCTF is a multi-component manufactured formulation used primarily for skin-quality treatment.

Exosome-based products belong to a different biological category.

The fact that both may be used with mesotherapy or microneedling does not make them equivalent.

Exosomes vs Jalupro

Jalupro formulations are based on defined injectable components such as amino acids and hyaluronic-acid-related formulations, depending on the product.

Exosome preparations contain extracellular-vesicle-related biological material.

They are different categories.

Exosomes vs Skin Boosters

Skin boosters commonly use manufactured formulations designed primarily around hydration and skin quality.

Exosome-related products are intended to act through biological signaling associated with extracellular vesicles.

Neither should be selected merely according to which treatment sounds more technologically advanced.

Exosomes vs Collagen Stimulators

PLLA and CaHA are biomaterials used to create characteristic tissue responses, including collagen-related remodeling.

Exosomes are extracellular vesicles.

Therefore:

PLLA/CaHA ≠ exosome treatment.

Exosomes vs Stem Cells

This distinction deserves repetition because the terms are frequently mixed in aesthetic marketing.

Stem Cell

A living cell.

Exosome

A non-cellular extracellular vesicle released by cells.

An exosome cannot divide, differentiate or become a new tissue in the way a living stem cell can.

Calling exosomes “stem cells” is biologically inaccurate.

Exosomes vs Conditioned Media

These terms should also not automatically be used interchangeably.

Conditioned media refers broadly to the culture medium that has been exposed to cells and can contain many secreted components.

It may contain:

  • Proteins
  • Cytokines
  • Growth factors
  • Extracellular vesicles
  • Other soluble molecules

A purified or characterized extracellular-vesicle preparation is therefore conceptually different from unseparated conditioned media.

Are Exosomes Injected?

This depends on the specific product, intended route of administration and applicable regulatory framework.

A product intended for topical or post-procedural use should not automatically be assumed to be appropriate for injection.

This is particularly important with biologically derived products.

The route of administration must match the characteristics and intended use of the specific preparation.

Does a Higher Exosome Count Mean a Better Product?

Not necessarily.

Marketing frequently emphasizes particle counts such as “billions of exosomes.”

A large numerical claim alone does not establish:

  • Purity
  • Biological activity
  • Identity
  • Safety
  • Clinical effectiveness

Particle characterization and manufacturing quality are more complex than a single number.

More particles do not automatically mean a better clinical treatment.

Are Plant Exosomes and Human Cell-Derived Exosomes the Same?

No.

Products described with terms such as plant-derived vesicles, exosome-like vesicles and human-cell-derived extracellular vesicles should not automatically be treated as biologically equivalent.

Their origin, cargo and biological behavior can differ substantially.

The exact product should therefore be identified rather than relying only on the word “exosome.”

How Many Exosome Sessions Are Needed?

There is no scientifically universal session number for every product and indication.

Treatment planning depends on:

  • Product
  • Indication
  • Route of use
  • Combination procedure
  • Patient characteristics
  • Clinical response

A standardized commercial package should not replace reassessment.

When Are Results Seen?

The answer depends heavily on what is being treated and which product is used.

Any biological remodeling should be expected to develop over time rather than immediately.

Early changes following microneedling or laser may also reflect the procedure itself rather than the exosome product alone.

Are Exosome Results Permanent?

No general claim of permanent results is appropriate.

Skin aging continues.

Androgenetic hair loss can continue.

The duration of any clinical benefit depends on the indication, product and patient.

Safety of Exosome Treatments

Safety cannot be evaluated simply by saying:

“Exosomes are natural.”

Important considerations include:

  • Biological source
  • Manufacturing standards
  • Purification
  • Sterility
  • Storage
  • Product characterization
  • Intended route of administration
  • Regulatory status
  • Clinical evidence

Potential risks also depend on how and where the product is used.

Dr. Fatih Ceran's Approach to Exosome Treatments

The starting point should not be:

“Exosomes are the newest technology, so they must be the best treatment.”

Instead, the questions should be:

What is the diagnosis?

Is the problem located in the skin, hair follicle, subcutaneous tissue or deeper facial anatomy?

What is the evidence for the proposed product?

What exactly does the product contain?

What is its source?

How was it manufactured and characterized?

How is it intended to be used?

Would another treatment provide a more predictable solution?

Depending on the problem, alternatives may include:

  • PRP
  • Polynucleotides
  • Skin boosters
  • NCTF
  • Jalupro
  • Collagen stimulators
  • Microneedling
  • Fractional laser
  • Medical hair-loss management
  • Hair transplantation
  • Surgery

The treatment sequence should remain:

diagnosis → anatomical/biological target → evidence → product → route of application → treatment plan → reassessment.

A sophisticated name does not make a treatment sophisticated.

The product, indication and biological rationale must make sense together.

Frequently Asked Questions About Exosomes

What are exosomes?

Exosomes are small extracellular vesicles involved in communication between cells.

Are exosomes stem cells?

No. Exosomes are cell-free extracellular vesicles; stem cells are living cells.

What does “stem-cell exosome” mean?

It may refer to extracellular vesicles produced by cultured stem or stromal cells. The vesicles themselves are not stem cells.

Are exosomes the same as PRP?

No. PRP is prepared from the patient's blood, whereas commercial exosome products involve extracellular-vesicle-related preparations.

Are exosomes the same as Salmon DNA?

No. PN/PDRN are nucleotide-based materials, while exosomes are extracellular vesicles.

Can exosomes be combined with microneedling?

Selected products may be used around microneedling protocols, but product sterility, formulation and intended route are important.

Can exosomes be used after fractional laser?

Some exosome-related products are discussed for use with procedural treatments, but suitability depends on the specific product and intended use.

Do exosomes grow new hair?

They should not be expected to create new follicles where follicles have been permanently lost.

Are exosomes better than PRP for hair?

There is no basis for saying that all exosome products are universally superior to PRP. Product standardization, evidence and the cause of hair loss matter.

Can exosomes replace hair transplantation?

No. Hair transplantation relocates viable follicles; exosome-based treatment does not perform follicular replacement.

Can exosomes be injected?

That depends on the specific product, its intended route and applicable regulatory framework. A topical product should not automatically be treated as an injectable.

Are exosome treatments permanent?

No universal permanent effect can be promised. Results depend on the indication, product and individual biological response.

Ask about Exosome Treatment

Leave your name and number and our team will contact you on WhatsApp. If you’d rather not wait, you can message us right away.

WhatsApp Consultation

or call: +90 552 313 02 96